Apellis Pharmaceuticals (APLS) Shares Outstanding (2020 - 2025)
Historic Shares Outstanding for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to $126.5 million.
- Apellis Pharmaceuticals' Shares Outstanding rose 362.99% to $126.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $126.5 million, marking a year-over-year increase of 362.99%. This contributed to the annual value of $124.5 million for FY2024, which is 413.11% up from last year.
- As of Q3 2025, Apellis Pharmaceuticals' Shares Outstanding stood at $126.5 million, which was up 362.99% from $126.2 million recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Shares Outstanding registered a high of $126.5 million during Q3 2025, and its lowest value of $80.4 million during Q1 2021.
- For the 5-year period, Apellis Pharmaceuticals' Shares Outstanding averaged around $111.6 million, with its median value being $117.6 million (2023).
- Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 11512577.75% in 2021, then soared by 313.45% in 2024.
- Over the past 5 years, Apellis Pharmaceuticals' Shares Outstanding (Quarter) stood at $97.5 million in 2021, then grew by 13.58% to $110.8 million in 2022, then grew by 7.93% to $119.6 million in 2023, then grew by 4.13% to $124.5 million in 2024, then grew by 1.61% to $126.5 million in 2025.
- Its Shares Outstanding was $126.5 million in Q3 2025, compared to $126.2 million in Q2 2025 and $125.7 million in Q1 2025.